NeoStem Inc recently received a grant of $17.7 million to fund the company’s effort in research of cell therapy products for cancer from California Institute of Regenerative Medicine. Following the announcement of the grant, shares of NeoStem rose by over 20 percent.
NeoStem CEO Dr. David Mazzo was on Fox Business News recently to talk about the company’s new cancer drug.
Hey, check out all the research scientist jobs. Post your resume today!
